Andres Forero-Torres
4PUBLICATIONS
48CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Jun 27, 2024
Adjuvant Trastuzumab Emtansine Versus Paclitaxel Plus Trastuzumab for Stage I Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: 5-Year Results and Correlative Analyses From ATEMPT.Paolo Tarantino, Nabihah Tayob, Guillermo Villacampa
|Feb 03, 2023
A phase I/II study of preoperative letrozole, everolimus, and carotuximab in stage 2 and 3 hormone receptor-positive and Her2-negative breast cancer.Christos Vaklavas, Erica M Stringer-Reasor, Ahmed M Elkhanany
|Aug 31, 2021
Efficacy of tucatinib for HER2-positive metastatic breast cancer after HER2-targeted therapy: a network meta-analysis.Kendra DeBusk, Shaun Abeysinghe, Adrian Vickers
|Jun 02, 2021
Adjuvant Trastuzumab Emtansine Versus Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT): A Randomized Clinical Trial.Sara M Tolaney, Nabihah Tayob, Chau Dang
Pageof 1
Frequent Collaborators
2 joint publications
Sara M Tolaney
2 joint publications
Nabihah Tayob
2 joint publications
Steven J Isakoff
2 joint publications
Therese Mulvey
2 joint publications
Ron Bose
2 joint publications
Antonio C Wolff
2 joint publications
Katherine Reeder-Hayes
2 joint publications
Hope S Rugo
2 joint publications
Dan Zuckerman
2 joint publications
Vijayakrishna K Gadi
